Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|
| Revenue | 5.84B | 5.34B | 5.32B | 4.72B | 4.38B | 4.17B |
| Cost of revenue | — | — | — | 2.41B | 2.30B | 2.17B |
| Gross profit | 2.91B | 2.65B | 2.68B | 2.31B | 2.07B | 2.00B |
| Research and development | 583M | 573M | 576M | 526M | 495M | 495M |
| Selling, general and administrative | 280M | 268M | 279M | 226M | 244M | 243M |
| Operating expenses | 864M | 841M | 856M | 752M | 739M | 738M |
| Operating income | 2.05B | 1.81B | 1.83B | 1.56B | 1.33B | 1.26B |
| Pre-tax income | 2.01B | 1.84B | 1.86B | 1.54B | 1.35B | 1.29B |
| Income tax | 186M | 243M | 291M | 206M | 157M | 178M |
| Net income | 1.83B | 1.59B | 1.57B | 1.33B | 1.19B | 1.12B |
| Earnings per share | 1.46 | 1.27 | 1.24 | 1.04 | 0.93 | 0.86 |
| Earnings per share, diluted | 1.45 | 1.26 | 1.24 | 1.03 | 0.92 | 0.86 |
| Weighted average shares | 1.25B | 1.25B | 1.26B | 1.28B | 1.29B | 1.30B |
| Weighted average shares, diluted | 1.26B | 1.26B | 1.27B | 1.29B | 1.29B | 1.30B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.75B | 6.18B | 6.69B | 6.39B | 5.45B | 5.67B | 6.07B | 5.85B |
| Receivables | 4.13B | 3.49B | 3.63B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 1.78B | — | — | 1.57B |
| Depreciation and amortisation | — | — | 102M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3.38B |
| 3.23B |
| 3.30B |
| 2.94B |
| 2.52B |
| Inventory | 4.00B | 4.04B | 4.10B | 4.31B | 4.46B | 4.36B | 4.21B | 4.22B |
| Current assets | 13.30B | 14.02B | 14.81B | 14.52B | 13.46B | 13.61B | 13.49B | 12.88B |
| Goodwill | — | — | — | — | — | — | — | 1.63B |
| Total assets | 20.79B | 21.39B | 21.90B | 21.35B | 19.97B | 19.84B | 19.53B | 18.74B |
| Current liabilities | 5.24B | 6.21B | 6.71B | 6.57B | 5.49B | 5.35B | 5.34B | 4.34B |
| Long-term debt | 3.73B | 3.73B | 3.73B | 3.73B | 3.73B | 4.48B | 4.48B | 4.48B |
| Total liabilities | 10.21B | 11.25B | 11.71B | 11.48B | 10.46B | 11.03B | 11.06B | 10.21B |
| Equity | 10.58B | 10.15B | 10.19B | 9.86B | 9.51B | 8.81B | 8.47B | 8.54B |
| Shares outstanding | 1.25B | 1.25B | 1.26B | 1.27B | 1.28B | 1.28B | 1.29B | 1.30B |
| Shares issued | 1.25B | 1.25B | 1.26B | 1.27B | 1.28B | 1.28B | 1.29B | 1.30B |
| Treasury shares | 1.71B | 1.71B | 1.70B | 1.69B | 1.67B | 1.67B | 1.66B | 1.65B |
| — |
| — |
| 94M |
| Share-based compensation | 97M | 89M | 97M | 87M | 82M | 80M |
| Capital expenditure | — | — | 185M | — | — | 111M |
| Investing cash flow | — | — | −186M | — | — | −111M |
| Dividends paid | — | — | 292M | — | — | 261M |
| Share buybacks | — | — | 976M | — | — | 997M |
| Financing cash flow | — | — | −1.28B | — | — | −1.26B |